NEW ORLEANS, LA--(Marketwired - Sep 9, 2013) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until November 8, 2013 to file lead plaintiff applications in a securities class action lawsuit against MiMedx Group, Inc. (
What You May Do
If you purchased shares of MiMedx and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, call toll-free at 1-877-515-1850, or email KSF Managing Partner Lewis Kahn (email@example.com) or KSF Partner Melinda Nicholson (firstname.lastname@example.org). If you wish to serve as a lead plaintiff in this class action, you must petition the Court by November 8, 2013.
About the Lawsuit
MiMedx and certain of its executives are charged with issuing a series of materially false and misleading statements about whether its AmnioFix product required U.S. Food and Drug Administration ("FDA") approval to be manufactured and marketed during the Class Period, violating federal securities laws.
On September 4, 2013, MiMedx confirmed receipt of an "Untitled Letter" the FDA sent to MiMedx on August 28, which stated that MiMedx's Surgical Biologics unit violated the Public Health Service Act by unlawfully manufacturing and marketing drugs that are also a biological product without a valid biologics license.
On this news, the price of MiMedx's shares fell drastically, by over 36%.
About Kahn Swick & Foti, LLC
To learn more about KSF, whose partners include the Former Louisiana Attorney General, Charles C. Foti, Jr., and other lawyers with significant experience litigating complex securities class actions nationwide on behalf of both institutional and individual shareholders, you may visit www.ksfcounsel.com.